Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Completed | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Amgen | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Children's Oncology Group | 1 |
| Chinese University of Hong Kong | 1 |
| Hong Kong Children's Hospital | 1 |
| National Hospital Organization Nagoya Medical Center | 1 |
| The University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Burkitt Lymphoma | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Neoplasms | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Down Syndrome | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Hypereosinophilic Syndrome | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.